C
Chui Ming Gemmy Cheung
Researcher at National University of Singapore
Publications - 235
Citations - 10749
Chui Ming Gemmy Cheung is an academic researcher from National University of Singapore. The author has contributed to research in topics: Macular degeneration & Medicine. The author has an hindex of 41, co-authored 193 publications receiving 7184 citations. Previous affiliations of Chui Ming Gemmy Cheung include Singapore National Eye Center & SingHealth.
Papers
More filters
Journal ArticleDOI
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.
Wan-Ling Wong,Xinyi Su,Xiang Li,Chui Ming Gemmy Cheung,Ronald Klein,Ching-Yu Cheng,Tien Yin Wong +6 more
TL;DR: In this article, the authors did a systematic literature review to identify all population-based studies of age-related macular degeneration published before May, 2013, using retinal photographs and standardised grading classifications.
Journal ArticleDOI
International Photographic Classification and Grading System for Myopic Maculopathy
Kyoko Ohno-Matsui,Ryo Kawasaki,Jost B. Jonas,Chui Ming Gemmy Cheung,Seang-Mei Saw,Virginie J. M. Verhoeven,Caroline C W Klaver,Muka Moriyama,Kosei Shinohara,Yumiko Kawasaki,Mai Yamazaki,Stacy M. Meuer,Tatsuro Ishibashi,Miho Yasuda,Hidetoshi Yamashita,Akira Sugano,Jie Jin Wang,Paul Mitchell,Tien Yin Wong +18 more
TL;DR: A classification system for myopic maculopathy that was found to be reproducible was proposed and applying a uniform classification in different studies will facilitate communication and comparison of findings from clinical trials and epidemiologic studies.
Journal ArticleDOI
Choroidal vascularity index as a measure of vascular status of the choroid: Measurements in healthy eyes from a population-based study
Rupesh Agrawal,Rupesh Agrawal,Preeti Gupta,Preeti Gupta,Kara-Anne Tan,Chui Ming Gemmy Cheung,Chui Ming Gemmy Cheung,Tien Yin Wong,Tien Yin Wong,Ching-Yu Cheng,Ching-Yu Cheng +10 more
TL;DR: While SFCT was affected by many factors, CVI remained unaffected suggesting CVI to be a more robust marker of choroidal diseases.
Journal ArticleDOI
Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians.
Chee Wai Wong,Yasuo Yanagi,Won Ki Lee,Yuichiro Ogura,Ian Yeo,Tien Yin Wong,Chui Ming Gemmy Cheung +6 more
TL;DR: Current clinical trials of intravitreal anti-VEGF therapy and photodynamic therapy will provide clearer perspectives of evidence-based management of PCV and may lead to paradigm shifts in therapeutic strategies away from those currently employed in the treatment of CNV-AMD.
Journal ArticleDOI
Polypoidal Choroidal Vasculopathy: Definition, Pathogenesis, Diagnosis, and Management.
Chui Ming Gemmy Cheung,Timothy Y Y Lai,Paisan Ruamviboonsuk,Shih-Jen Chen,Youxin Chen,K. Bailey Freund,Fomi Gomi,Adrian Koh,Won Ki Lee,Tien Yin Wong +9 more
TL;DR: 2 large, multicenter randomized clinical trials evaluating the safety and efficacy of anti-VEGF monotherapy and combination with photodynamic therapy (PDT) recently reported initial first-year outcomes, providing level I evidence to guide clinicians in choosing the most appropriate therapy for PCV.